EntryPoint Capital’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-516	Closed	-$71.2K	–	1367
2024 Q1	$71.2K	Buy	516 +223	+76%	+$30.8K	0.06%	594
2023 Q4	$38.6K	Buy	+293	New	+$38.6K	0.04%	840